Synthesis and antiviral activity of novel fluorinated 2',3'-dideoxynucleosides. 2004

Piyush Kumar, and Kazue Ohkura, and Jan Balzarini, and Erik De Clercq, and Koh-ichi Seki, and Leonard I Wiebe
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.

A series of 5-(trifluoroethoxymethyl)-2',3'-dideoxyuridines and 5-[bis(trifluoroethoxy)-methyl]-2',3'-dideoxyuridines have been prepared and screened for antiviral activity. The conformations of these compounds are discussed on the bases of NOE studies and the MO calculations. Modelling and NOE studies suggest both syn- and anti conformations for these 5-(2,2,2-trifluoroethoxymethyl)- and 5-[bis(2,2,2-trifluoroethoxy)-methyl]- derivatives. The NOE parameters are also suggested to be more attributable to the nature of the fluorine atom than to structural or conformational changes. Compounds 17, 26 and 30 showed some activity in anti-HIV-1 and anti-HIV-2 assays, but the compounds were devoid of activity against HSV and human rhinovirus. The compounds tested exhibited low cytotoxicity and were inactive against a bank of cancer cells in vitro.

UI MeSH Term Description Entries
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D014777 Virus Diseases A general term for diseases caused by viruses. Viral Diseases,Viral Infections,Virus Infections,Disease, Viral,Disease, Virus,Diseases, Viral,Diseases, Virus,Infection, Viral,Infection, Virus,Infections, Viral,Infections, Virus,Viral Disease,Viral Infection,Virus Disease,Virus Infection
D014780 Viruses Minute infectious agents whose genomes are composed of DNA or RNA, but not both. They are characterized by a lack of independent metabolism and the inability to replicate outside living host cells. Animal Viruses,Zoophaginae,Animal Virus,Virus,Virus, Animal,Viruses, Animal
D015224 Dideoxynucleosides Nucleosides that have two hydroxy groups removed from the sugar moiety. The majority of these compounds have broad-spectrum antiretroviral activity due to their action as antimetabolites. The nucleosides are phosphorylated intracellularly to their 5'-triphosphates and act as chain-terminating inhibitors of viral reverse transcription. 2',3'-Dideoxynucleosides,Dideoxyribonucleosides,ddNus,2',3' Dideoxynucleosides

Related Publications

Piyush Kumar, and Kazue Ohkura, and Jan Balzarini, and Erik De Clercq, and Koh-ichi Seki, and Leonard I Wiebe
April 2001, Archives of pharmacal research,
Piyush Kumar, and Kazue Ohkura, and Jan Balzarini, and Erik De Clercq, and Koh-ichi Seki, and Leonard I Wiebe
January 2013, Monatshefte fur chemie,
Piyush Kumar, and Kazue Ohkura, and Jan Balzarini, and Erik De Clercq, and Koh-ichi Seki, and Leonard I Wiebe
February 1992, Journal of medicinal chemistry,
Piyush Kumar, and Kazue Ohkura, and Jan Balzarini, and Erik De Clercq, and Koh-ichi Seki, and Leonard I Wiebe
November 1991, Acta chemica Scandinavica (Copenhagen, Denmark : 1989),
Piyush Kumar, and Kazue Ohkura, and Jan Balzarini, and Erik De Clercq, and Koh-ichi Seki, and Leonard I Wiebe
May 2008, The Journal of organic chemistry,
Piyush Kumar, and Kazue Ohkura, and Jan Balzarini, and Erik De Clercq, and Koh-ichi Seki, and Leonard I Wiebe
September 1990, Journal of medicinal chemistry,
Piyush Kumar, and Kazue Ohkura, and Jan Balzarini, and Erik De Clercq, and Koh-ichi Seki, and Leonard I Wiebe
July 1987, Journal of medicinal chemistry,
Piyush Kumar, and Kazue Ohkura, and Jan Balzarini, and Erik De Clercq, and Koh-ichi Seki, and Leonard I Wiebe
July 1992, Journal of medicinal chemistry,
Piyush Kumar, and Kazue Ohkura, and Jan Balzarini, and Erik De Clercq, and Koh-ichi Seki, and Leonard I Wiebe
January 1991, Nucleic acids symposium series,
Piyush Kumar, and Kazue Ohkura, and Jan Balzarini, and Erik De Clercq, and Koh-ichi Seki, and Leonard I Wiebe
January 1999, Nucleosides & nucleotides,
Copied contents to your clipboard!